Leadership Overview
Tolmar has 6 executives leading key functions including strategy, financial oversight, medical marketing, operational management, legal compliance, and North American commercial expansion.
Committed to advancing specialty pharmaceutical solutions, Tolmar drives innovation through integrated development and manufacturing processes to improve patient outcomes across diverse therapeutic areas.
Committed to advancing specialty pharmaceutical solutions, Tolmar drives innovation through integrated development and manufacturing processes to improve patient outcomes across diverse therapeutic areas.
Leadership Roles at Tolmar
Anil D'Souza - Chief Executive Officer
Anil D'Souza, the Chief Executive Officer at Tolmar, directs the overarching strategic vision and long-term growth trajectory for the organization. By aligning research initiatives with market demands, the Chief Executive Officer ensures the company maintains a competitive edge in the specialty pharmaceutical sector. Anil D'Souza oversees the integration of product development and manufacturing operations, fostering a culture of excellence across all facilities. This leadership role involves constant collaboration with the Board to secure capital investments and drive sustainable expansion. Through rigorous oversight of corporate governance, the Chief Executive Officer maintains high standards of operational integrity. By prioritizing innovation in urology and other therapeutic areas, the Chief Executive Officer positions the firm for continued success in the global marketplace. This executive leadership remains focused on delivering high-quality pharmaceutical products to patients while maximizing value for all stakeholders involved in the enterprise.
Jeff Lederman - Chief Financial Officer
Jeff Lederman, the Chief Financial Officer at Tolmar, manages the fiscal health and capital allocation strategies necessary for sustained pharmaceutical innovation. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the company maintains a robust balance sheet to support complex manufacturing requirements. Jeff Lederman directs the budgeting processes that fuel product development cycles, ensuring resources align with the firm's long-term commercial goals. This leadership role involves frequent interaction with the executive team to evaluate investment opportunities and optimize cost structures across North American operations. By implementing advanced financial controls, the Chief Financial Officer safeguards the organization against market volatility. Through precise analysis of revenue streams and operational expenditures, the Chief Financial Officer drives the financial stability required to advance specialty pharmaceutical projects. This executive leadership remains dedicated to maintaining fiscal transparency and supporting the company's mission through disciplined financial management.
Shawn Silvestri - President & Chief Operating Officer
Shawn Silvestri, the President & Chief Operating Officer at Tolmar, manages the daily execution of manufacturing and product development activities. Overseeing the operational infrastructure, the President & Chief Operating Officer ensures that facilities maintain the highest standards of quality and efficiency. Shawn Silvestri directs the supply chain and production teams to meet the demands of the specialty pharmaceutical market. This leadership role involves coordinating cross-functional workflows to streamline the transition from development to commercialization. By optimizing manufacturing processes, the President & Chief Operating Officer reduces lead times and enhances overall productivity. Through rigorous oversight of operational performance, the President & Chief Operating Officer supports the company's ability to scale production in response to market growth. This executive leadership remains committed to operational excellence, ensuring that the firm delivers reliable, high-quality pharmaceutical solutions to patients while maintaining a competitive manufacturing footprint across the North American region.
Steve Griffin - President (North America)
Steve Griffin, the President (North America) at Tolmar, directs the commercial strategy and regional operations across the North American market. Overseeing the sales and distribution networks, the President (North America) ensures that specialty pharmaceutical products reach healthcare providers and patients efficiently. Steve Griffin manages the commercial headquarters to drive revenue growth and expand market share in key therapeutic areas. This leadership role involves coordinating with the executive team to align regional sales efforts with the company's broader manufacturing and development goals. By analyzing market trends and competitive dynamics, the President (North America) optimizes the commercial approach to maximize impact. Through strategic leadership of the regional team, the President (North America) strengthens the company's presence and ensures consistent delivery of high-value medical solutions. This executive leadership remains dedicated to achieving commercial success and fostering strong relationships with healthcare partners throughout the North American region.
Anjan Chatterjee - Chief Medical Officer & Chief Marketing Officer
Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, bridges the gap between clinical research and commercial market entry. Overseeing the medical strategy for specialty pharmaceuticals, the Chief Medical Officer & Chief Marketing Officer ensures that product development aligns with unmet patient needs in urology. Anjan Chatterjee directs the marketing teams to communicate the clinical value of the company's portfolio to healthcare providers across North America. This leadership role involves managing clinical trials and regulatory communications while simultaneously driving brand awareness and market penetration. By synthesizing complex medical data into actionable commercial insights, the Chief Medical Officer & Chief Marketing Officer accelerates the adoption of innovative therapies. Through strategic engagement with medical professionals, the Chief Medical Officer & Chief Marketing Officer strengthens the company's reputation as a leader in specialty medicine. This executive leadership remains focused on improving patient outcomes through evidence-based marketing and clinical excellence.
Michael Elm - Chief Legal Officer
Michael Elm, the Chief Legal Officer at Tolmar, directs the legal strategy and regulatory compliance framework for the entire organization. Overseeing intellectual property protection, the Chief Legal Officer ensures that the company's innovative pharmaceutical developments remain secure in a competitive landscape. Michael Elm manages complex contract negotiations and corporate governance matters, providing the legal foundation for all commercial activities. This leadership role involves advising the executive team on risk mitigation and regulatory requirements across various jurisdictions. By navigating the intricate legal environment of the pharmaceutical industry, the Chief Legal Officer safeguards the firm's interests and reputation. Through proactive legal counsel, the Chief Legal Officer supports the company's mission to bring specialty therapies to market while adhering to strict industry standards. This executive leadership remains focused on maintaining ethical compliance and protecting the long-term value of the company's intellectual assets through diligent legal oversight.
Explore Leadership Teams in Manufacturing
Founded in 1974, Apotex is a proud Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world.
Company Leadership
DA
TM
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership PP
MH
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
KW
FC
Eris Lifesciences Ltd is a prominent Indian pharmaceutical company specializing in branded formulations, particularly in the cardio-metabolic sector. The company offers a diverse range of products across various therapeutic areas including anti-diabetes, cardiovascular health, dermatology, and gynecology. Eris is committed to improving patient care through innovative initiatives and pioneering studies aimed at chronic lifestyle-related diseases. Their target clients include healthcare professionals and patients across India, with a focus on enhancing health outcomes.
Company Leadership VK
GA
MM
Frequently Asked Questions Regarding Tolmar Top Executives and Leadership Team
Unlock more people and company data
